-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q2 2024.
- Corbus Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.29M, a 56.5% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.89M, a 12.8% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.47M, a 39.3% decline from 2022.
- Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.72M, a 39.7% decline from 2021.
- Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.48M, a 23.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)